In this context, the results showed that luteolin may regulate the response to inorganic substances, to oxidative stress, the apoptotic signaling pathway, the protein kinase complex, and a series of kinase activities to exert its therapeutic effects on glioma disease (Figure 4). This evidence concerns the gene WEE1 and central nervous system cancer.